Yunhe Pharmaceutical (tianjin) Co., Ltd

This study tests a new drug called INR102 in people with a specific type of advanced prostate cancer (PSMA-positive) that no longer responds to hormone therapy. The goal is to see if the drug is safe, how it moves through the body, and whether it can shrink tumors or lower PSA le…